Home » Roche’s Next Generation Roponin T Test Gets FDA Approval
Roche’s Next Generation Roponin T Test Gets FDA Approval
The FDA has granted marketing approval to Roche’s Troponin T test as an aid in the diagnosis of myocardial infarction.
The device reports the troponin biomarker within nine minutes. — Cynthia Jessup
Upcoming Events
-
07May
-
14May
-
30May